CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lycia Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lycia Therapeutics Inc
400 East Jamie Court, Suite 200
Phone: (302) 658-7581p:302 658-7581 SOUTH SAN FRANCISCO, CA  94080  United States Ticker: LYCALYCA
Business Summary
Lycia Therapeutics Inc., established in 2019, is a biotechnology company. It focuses on discovering and developing therapeutics that degrade proteins associated with difficult-to-treat diseases, including immunological and inflammatory diseases.
(Source: AI Generated Content – Human Reviewed & Approved)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202612/31/2025YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board William J.Rieflin 66 12/1/2020
President, Chief Executive Officer, Director WunTrombley 47 4/1/2020
Chief Financial Officer AmyBachrodt 47 6/1/2026 6/1/2026
5 additional Officers and Directors records available in full report.

Business Names
Business Name
LYCA
LYCIA THERAPEUTICS INC

General Information
Number of Employees: 31 (As of 6/30/2026)
Outstanding Shares: 55,034,559 (As of 6/30/2026)
Stock Exchange: NASD
Federal Tax Id: 843860514
Fax Number: (302) 655-5049
Email Address: info@lyciatx.com


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, November 14, 2026